https://revistafarmaiq.com/wp-content/uploads/2023/01/Bepanthen_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-31 13:53:032023-01-31 13:53:06DISFRUTA DE UNA PIEL LIBRE DE ECCEMA CON BEPANTHEN® SENSICALM Y SENSICONTROL
https://revistafarmaiq.com/wp-content/uploads/2023/01/dravet_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-20 13:54:122023-01-20 13:54:14LA CONFERENCIA INTERNACIONAL SOBRE EL SÍNDROME DE DRAVET 2023 SE CELEBRARÁ EN MARZO EN MADRID
https://revistafarmaiq.com/wp-content/uploads/2023/01/viruses_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-19 11:11:002023-01-19 00:52:42RETA SILANES A LA INFLUENZA CON PRIMER ANTIVIRAL QUE INHIBE LA REPLICACIÓN DEL VIRUS
https://revistafarmaiq.com/wp-content/uploads/2023/01/biadit_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-13 11:11:002023-01-13 01:19:52COFEPRIS ALERTA SOBRE PRODUCTO ENGAÑO PARA PACIENTES CON DIABETES
https://revistafarmaiq.com/wp-content/uploads/2023/01/obesidad_2-1.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-11 11:11:002023-01-10 23:08:46CINCO RAZONES QUE PROVOCAN POSTERGACIÓN AL TRATAMIENTO DE OBESIDAD
https://revistafarmaiq.com/wp-content/uploads/2023/01/anfitrion_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-09 11:11:002023-01-10 22:09:39MÉXICO SERÁ ANFITRIÓN DEL XVIII ENCUENTRO INTERNACIONAL DE FARMACOVIGILANCIA DE LAS AMÉRICAS
https://revistafarmaiq.com/wp-content/uploads/2022/12/isste_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-12-14 11:12:002022-12-14 14:43:09COFEPRIS E ISSSTE ESTABLECEN MESA DE TRABAJO PARA LA MEJORA REGULATORIA EN UNIDADES MÉDICAS
https://revistafarmaiq.com/wp-content/uploads/2022/12/pcr_1.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-12-09 11:11:002022-12-09 00:28:58COFEPRIS DA A CONOCER LOS RESULTADOS DE LOS ANÁLISIS ENTREGADOS AL ESTADO DE DURANGO SOBRE LOS CASOS DE MENINGITIS
https://revistafarmaiq.com/wp-content/uploads/2022/12/rxAntad_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2022-12-08 09:09:002022-12-07 19:37:54RX Y ANTAD SE UNEN PARA PRESENTAR EXPO FAC, FARMACIAS Y CUIDADO PERSONAL 2023 EN EXPO GUADALAJARA
https://revistafarmaiq.com/wp-content/uploads/2023/01/Bepanthen_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-31 13:53:032023-01-31 13:53:06DISFRUTA DE UNA PIEL LIBRE DE ECCEMA CON BEPANTHEN® SENSICALM Y SENSICONTROL
https://revistafarmaiq.com/wp-content/uploads/2023/01/dravet_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-20 13:54:122023-01-20 13:54:14LA CONFERENCIA INTERNACIONAL SOBRE EL SÍNDROME DE DRAVET 2023 SE CELEBRARÁ EN MARZO EN MADRID
https://revistafarmaiq.com/wp-content/uploads/2023/01/viruses_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-19 11:11:002023-01-19 00:52:42RETA SILANES A LA INFLUENZA CON PRIMER ANTIVIRAL QUE INHIBE LA REPLICACIÓN DEL VIRUS
https://revistafarmaiq.com/wp-content/uploads/2023/01/biadit_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-13 11:11:002023-01-13 01:19:52COFEPRIS ALERTA SOBRE PRODUCTO ENGAÑO PARA PACIENTES CON DIABETES
https://revistafarmaiq.com/wp-content/uploads/2023/01/obesidad_2-1.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-11 11:11:002023-01-10 23:08:46CINCO RAZONES QUE PROVOCAN POSTERGACIÓN AL TRATAMIENTO DE OBESIDAD
https://revistafarmaiq.com/wp-content/uploads/2023/01/anfitrion_0.jpg321845Nestor Rodriguezhttps://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.pngNestor Rodriguez2023-01-09 11:11:002023-01-10 22:09:39MÉXICO SERÁ ANFITRIÓN DEL XVIII ENCUENTRO INTERNACIONAL DE FARMACOVIGILANCIA DE LAS AMÉRICAS
https://revistafarmaiq.com/wp-content/uploads/2023/01/Bepanthen_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-31 13:53:032023-01-31 13:53:06DISFRUTA DE UNA PIEL LIBRE DE ECCEMA CON BEPANTHEN® SENSICALM Y SENSICONTROL
https://revistafarmaiq.com/wp-content/uploads/2023/01/dravet_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-20 13:54:122023-01-20 13:54:14LA CONFERENCIA INTERNACIONAL SOBRE EL SÍNDROME DE DRAVET 2023 SE CELEBRARÁ EN MARZO EN MADRID
https://revistafarmaiq.com/wp-content/uploads/2023/01/viruses_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-19 11:11:002023-01-19 00:52:42RETA SILANES A LA INFLUENZA CON PRIMER ANTIVIRAL QUE INHIBE LA REPLICACIÓN DEL VIRUS
https://revistafarmaiq.com/wp-content/uploads/2023/01/biadit_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-13 11:11:002023-01-13 01:19:52COFEPRIS ALERTA SOBRE PRODUCTO ENGAÑO PARA PACIENTES CON DIABETES
https://revistafarmaiq.com/wp-content/uploads/2023/01/obesidad_2-1.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-11 11:11:002023-01-10 23:08:46CINCO RAZONES QUE PROVOCAN POSTERGACIÓN AL TRATAMIENTO DE OBESIDAD
https://revistafarmaiq.com/wp-content/uploads/2023/01/anfitrion_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2023-01-09 11:11:002023-01-10 22:09:39MÉXICO SERÁ ANFITRIÓN DEL XVIII ENCUENTRO INTERNACIONAL DE FARMACOVIGILANCIA DE LAS AMÉRICAS
https://revistafarmaiq.com/wp-content/uploads/2022/12/isste_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2022-12-14 11:12:002022-12-14 14:43:09COFEPRIS E ISSSTE ESTABLECEN MESA DE TRABAJO PARA LA MEJORA REGULATORIA EN UNIDADES MÉDICAS
https://revistafarmaiq.com/wp-content/uploads/2022/12/pcr_1.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2022-12-09 11:11:002022-12-09 00:28:58COFEPRIS DA A CONOCER LOS RESULTADOS DE LOS ANÁLISIS ENTREGADOS AL ESTADO DE DURANGO SOBRE LOS CASOS DE MENINGITIS
https://revistafarmaiq.com/wp-content/uploads/2022/12/rxAntad_0.jpg
321
845
Nestor Rodriguez
https://revistafarmaiq.com/wp-content/uploads/2015/05/Sin-título-1.png
Nestor Rodriguez2022-12-08 09:09:002022-12-07 19:37:54RX Y ANTAD SE UNEN PARA PRESENTAR EXPO FAC, FARMACIAS Y CUIDADO PERSONAL 2023 EN EXPO GUADALAJARA
